RARE position history
The shares of Ultragenyx Pharmaceutical In (RARE) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 48,750 shares, $1.8M, 0.38% of portfolio, New
- 2025 Q3: 369,531 shares, $11M, 2.1% of portfolio, Add +658.0%
- 2025 Q4: 461,294 shares, $11M, 1.5% of portfolio, Add +24.8%
- 2026 Q1: 596,495 shares, $12M, 1.9% of portfolio, Add +29.3%
- 2026 Q2: 596,495 shares, $20M, 2.8% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|